Title Identification of the cellular components involved in de novo immune hepatitis: a quantitative immunohistochemical analysis
Authors AGUADO DOMÍNGUEZ, ELENA, Gomez, Lourdes , Manuel Sousa, Jose , Angel Gomez-Bravo, Miguel , Nunez-Roldan, Antonio , Aguilera, Isabel
External publication Si
Means JOURNAL OF TRANSLATIONAL MEDICINE
Scope Article
Nature Científica
JCR Quartile 2
SJR Quartile 1
JCR Impact 4.098
Publication date 13/03/2018
ISI 000427958400002
DOI 10.1186/s12967-018-1440-8
Abstract Background: Diagnosis of de novo immune hepatitis (dnIH) after liver transplantation relies on biopsy findings, with an abundance of plasma cells (PCs) in the inflammatory infiltrates a hallmark of the disease. Very little is known about what other types of immune cells exist in the infiltrates mainly located in the portal areas of the liver tissue.\n Methods: We analyzed the composition of T cells, B cells, PCs, and macrophages in the liver biopsies of 12 patients with dnIH, 9 of them obtained at the time of diagnosis. For comparison, biopsies from 9 patients with chronic rejection (CR) were included in the study. The results were analyzed by a computer-assisted stereology quantification method.\n Results: The major components of the infiltrates in the portal areas were CD3(+) T lymphocytes in both groups, with 36.6% in the dnIH group versus 49.4% in the CR group. CD20(+) B lymphocytes represented 14.9% in the dnIH group and 29.1% in the CR group. Macrophage levels were very similar in the dnIH and CR group (19.7% versus 16.8%, respectively). PCs were much less represented in CR biopsies than those from the dnIH group (mean value of 4.7% versus 28.8%).\n Conclusion: In conclusion, the determination of a characteristic cellular profile could be an important tool for a more reliable diagnosis of dnIH, in support of the histological evaluation made by the pathologist, which in most cases is challenging. Recognition of this condition is crucial because it leads to graft failure if left untreated.
Keywords Inflammatory infiltrates; Liver biopsy; De novo immune hepatitis; newCAST; Chronic rejection; Donor/recipient mismatch; GSTT1
Universidad Loyola members

Change your preferences Manage cookies